Rituximab May Not Halt Progression to ESRD
BOSTON—Rituximab is highly effective for treating resistant systemic lupus erythematosus (SLE), but, in certain patients, the medication does not prevent progression to end-stage renal disease (ESRD), British researchers conclude.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.